自動注射器的全球市場（2023-2030）：按類型、應用和最終用戶分類的規模、佔有率、成長分析和預測

全球自動注射器市場規模預計將從 2021 年的 468 億美元成長到 2022 年的 563 億美元，到 2030 年成長到 2,473 億美元，預測期內年複合成長率為 17.9%。

近年來，由於慢性病盛行率增加、自我給藥設備需求增加以及技術進步等多種因素，全球自動注射器市場出現了顯著成長。自動注射器具有多種優點，包括易於使用、給藥準確和提高患者依從性。

另一方面，自動注射器的成本可能會抑制因素市場成長，特別是在患者經濟負擔令人擔憂的新興國家。與傳統注射器相比，自動注射器的價格較高可能會限制其在某些市場的採用。人們也擔心針刺傷的風險。這種安全問題可能會限制自動注射器的採用。

本報告調查了全球自動注射器市場，並提供了市場概況、市場各種影響因素分析、技術和創新趨勢、法律制度、市場規模趨勢和預測，以及各個細分市場和地區的細分。 、競爭形勢、主要企業簡介等。

目錄

• 執行摘要
• 調查方法
• 母市場分析
  • 市場概況
  • 市場規模
  • 市場動態
    • 促進因素
    • 機會
    • 抑制因素
    • 任務
• 關鍵市場洞察
  • 技術分析
  • 價格分析
  • 供應鏈分析
  • 價值鏈分析
  • 市場生態系統
  • 智慧財產權分析
  • 貿易分析
  • 啟動分析
  • 原料分析
  • 創新矩陣
  • 研發線產品分析
  • 總體經濟指標
  • 重點投資分析
  • 關鍵成功因素
  • 競爭程度
  • 市場動態及展望
    • 市場動態
      • 促進因素
      • 機會
      • 抑制因素
      • 任務
  • 法規狀況
  • 波特的分析
  • Skyquest 對未來顛覆的獨家見解
• 全球自動注射器市場：按類型
  • 市場概況
  • 一次性的
  • 可重複使用的
• 全球自動注射器市場：依應用分類
  • 市場概況
  • 類風濕性關節炎
  • 多發性硬化症
  • 過敏反應
  • 其他
• 全球自動注射器市場：依最終用戶分類
  • 市場概況
  • 居家醫療
  • 醫院/診所
  • 其他
• 全球自動注射器市場：按地區
  • 市場概況
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲
• 競爭形勢
  • 前5名企業對比
  • 主要企業市場地位
  • 主要企業的招募策略
  • 關鍵成功策略
  • 近期市集活動
  • 主要企業市場佔有率
• 主要企業簡介
  • Becton, Dickinson and Company
  • Eli Lilly and Company
  • Johnson & Johnson
  • Pfizer Inc.
  • Amgen Inc.
  • Mylan NV
  • Teva Pharmaceutical Industries Ltd.
  • Ypsomed AG
  • Antares Pharma, Inc.
  • Bespak Europe Ltd. (A Consort Medical Company)
  • Gerresheimer AG
  • SHL Medical AG
  • Owen Mumford Ltd.
  • Enable Injections
  • ScPharmaceuticals Inc.
  • Biogen Inc.
  • Novartis International AG
  • Merck & Co., Inc.
  • Consort Medical plc
  • Haselmeier AG

Global Auto Injector Market size was valued at USD 46.8 billion in 2021 and is poised to grow from USD 56.30 billion in 2022 to USD 247.3 billion by 2030, at a CAGR of 17.9% during the forecast period (2023-2030).

Autoinjectors are medical devices designed to deliver a specific dose of medication to patients. They are often used for the self-administration of drugs, such as epinephrine for severe allergic reactions or insulin for diabetes management. In recent years, the global auto injector market has experienced significant growth due to various factors, including the increasing prevalence of chronic diseases, rising demand for self-administration devices, and advancements in technology. Auto injectors offer several benefits, such as ease of use, accurate dosing, and improved patient compliance. Key players in the auto injector market include pharmaceutical companies, medical device manufacturers, and technology providers. These companies often compete in terms of product features, design, safety, and compatibility with different medications. Market dynamics, such as regulatory requirements, reimbursement policies, and patent protection, also influence the market landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Auto-Injector Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Auto-Injector Market Segmental Analysis

The auto injectors market is segmented on the basis of type, application, end user, and region. By type, it is categorized into disposable and reusable auto injectors. Based on application, it is divided into rheumatoid arthritis, multiple sclerosis, anaphylaxis, and others. By end user, it is categorized into home care settings and hospitals & clinics. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Auto-Injector Market Dynamics

Drivers of the Global Auto-Injector Market

Increasing Prevalence of Chronic Diseases

The rising incidence of chronic diseases, such as rheumatoid arthritis, multiple sclerosis, diabetes, and allergies, is a significant driver of the auto injector market. auto injectors offer a convenient and efficient way for patients to self-administer medications, empowering them to manage their conditions effectively.

There is a growing trend towards patient-centric healthcare, focusing on improving patient experience and promoting self-care. auto injectors provide patients with the ability to administer their medications at home, reducing the need for frequent hospital visits and enhancing their overall quality of life.

Restraints in the Global Auto Injector Market

High Cost of Auto Injectors

The cost of auto injector devices can be a restraint for market growth, particularly in emerging economies where affordability may be a concern for patients. The higher price of auto injectors compared to traditional syringes can limit their adoption in certain markets.

Despite the convenience they offer, auto injectors still involve needle usage, which can raise concerns about the risk of needlestick injuries. These safety concerns may limit their adoption, especially among patients who may be hesitant to self-administer injections.

Market Trends of the Global Auto Injector Key

The market is witnessing a notable trend towards self-administration of medications. Patients are increasingly seeking greater control and convenience in managing their treatment, leading to a rise in the adoption of auto injectors. These devices allow patients to self-administer medications accurately and easily, empowering them to take an active role in their healthcare journey.

Table of Contents

• Executive Summary
  • Market Overview
  • Wheel of Fortune
• Research Methodology
  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations
• Parent Market Analysis
  • Market Overview
  • Market Size
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
• Key Market Insights
  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition
• Market Dynamics & Outlook
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
  • Regulatory Landscape
  • Porters Analysis
• Competitive rivalry
• Threat of Substitute Products
• Bargaining Power of Buyers
• Threat of New Entrants
• Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
• Political Impact
• Economic Impact
• Social Impact
• Technical Impact
• Environmental Impact
• Legal Impact
• Global Auto Injector Market by Type
  • Market Overview
  • Disposable and reusable auto injectors
• Global Auto Injector Market by Application
  • Market Overview
  • Rheumatoid arthritis
  • multiple sclerosis
  • anaphylaxis
  • and others
• Global Auto Injector Market by End-user
  • Market Overview
  • Home care settings and hospitals & clinics others
• Global Auto Injector Market Size by Region
  • Market Overview
  • North America
• USA
• Canada
  • Europe
• Germany
• Spain
• France
• UK
• Rest of Europe
  • Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
  • Latin America
• Brazil
• Rest of Latin America
  • Middle East & Africa (MEA)
• GCC Countries
• South Africa
• Rest of MEA
• Competitive Landscape
  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
• By Development
• By Company
• By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021
• Key Company Profiles
  • Becton, Dickinson and Company (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Eli Lilly and Company (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Johnson & Johnson (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Pfizer Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Amgen Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Mylan N.V. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Teva Pharmaceutical Industries Ltd. (Israel)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Ypsomed AG (Switzerland)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Antares Pharma, Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Bespak Europe Ltd. (A Consort Medical Company), (UK)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Gerresheimer AG (Germany)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • SHL Medical AG (Switzerland)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Owen Mumford Ltd. (UK)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Enable Injections (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • ScPharmaceuticals Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Biogen Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Novartis International AG (Switzerland)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Merck & Co., Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Consort Medical plc (UK)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Haselmeier AG (Switzerland)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments